Forward P/S Multiple: Sintx Technologies Inc (SINT)

Sintx Technologies, Inc. - graphic logo of issuer SINT

The forward P/S trajectory of Sintx Technologies (SINT) demonstrates restrained market optimism, with the metric holding around 3.20. The company's own plant in Utah serves as the foundation, guaranteeing the quality of its bioceramics. Robotic high-precision implant processing ensures exceptional microscopic accuracy. Business stability is bolstered by a staff of rare materials science experts, which securely protects the internal engineering developments of Sintx Technologies (SINT).

Sintx Technologies, Inc. - SINT Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for sintx.com (SINT)

- market price and analyst price targets:
Price Chart Sintx Technologies, Inc.|SINT - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization SINT|SINT - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Sintx Technologies|SINT - Accounting Capitalization|Market Capitalization to Book Value Ratio sintx.com|SINT - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Sintx Technologies|SINT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Sintx Technologies, Inc.|SINT - Company Aggregate Debts|Debt to Book Capitalization Ratio SINT|SINT - Company Long-Term Debt|Company Current Liabilities Sintx Technologies|Quick Ratio sintx.com
- financial results and valuation multiples details:
SINT - Company Net Income|Expected Profit Sintx Technologies|SINT - Market Cap to Net Income Ratio|Projected Price to Earnings Sintx Technologies, Inc.|SINT - PEG Multiple|EV/EBITDA Multiple SINT|SINT - Operating income before deduction of amortization|Earnings per share for the last twelve months Sintx Technologies|SINT - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months sintx.com|SINT - Net earnings per share growth this year|Earnings growth forecast for next year Sintx Technologies
- sales and revenue indicators:
SINT - Company Total Revenue|Company Projected Revenue Sintx Technologies, Inc.|SINT - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple SINT
Fundamental company analysis:SINT (SINTX Technologies)
Product sample of sintx.com

Sintx Technologies' specialization in creating high-tech medical ceramics requires colossal R&D expenditures, making revenue a key indicator of business scaling. This metric correlates the company's current market value with expected sales volume, reflecting the degree of market optimism priced in. By analyzing the forward price-to-sales valuation trend, an investor can determine whether the company's future successes in biomaterials are overvalued.

Who Sintx Technologies competes with

Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Orthofix International - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bioventus Global BVS|OrthoPediatrics Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio treace.com TMCI|Strata Critical Medical (SRTA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CARL (Carlsmed, Inc.)|Price-to-Projected Revenue Ratio RxSight Corp|Forward Price-to-Revenue Multiple ClearPoint (CLPT)|Forward P/S Multiple STXS|STIM - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Sight Sciences SGHT|OBIO: Market Cap to Projected Revenue|ANIK: Forward Price-to-Revenue Multiple|InspireMD Inc. - Price to Expected Revenue Ratio|zhjmedical.com (ZJYL) - Price-to-Projected Revenue Ratio|VANI - Market Cap to Expected Sales Ratio|XTNT (Xtant Medical Holdings, Inc.) - Forward P/S Multiple|NeuroOne (NMTC) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Modular Medical (MODD)|Myomo Inc - Market Cap to Projected Revenue|Envoy Medical, Inc. - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio VVOS (vivoslife.com)|NVNO: Forward Price-to-Revenue Multiple|TNON (Tenon Medical Inc.) - Market Cap to Projected Revenue|LFWD (ReWalk Robotics Ltd) - Forward Price-to-Revenue Multiple|Autonomix Medical - Forward Price to Sales|Forward Price-to-Revenue Multiple IVF|BBLG (bonebiologics.com) - Price to Expected Revenue Ratio|Forward P/S Multiple AXNX|BIOL - Market Cap to Future Revenue Ratio|Forward P/S Multiple DYNT (Dynatronics)|FNA - Forward Price-to-Revenue Multiple|INVO Bio - Forward P/S Multiple